Table 1.
Participant characteristics.
| N | 26 |
|---|---|
| Mean age (SD) | 71 (9) |
| Male:Female | 18:8 |
| Race/Ethnicity | |
| White | 21 (81%) |
| White-Hispanic | 2 (8%) |
| Black | 4 (15%) |
| Asian | 1 (4%) |
| Mean # CV Risk Factors (IQR) | 2 (1) |
| Hyperlipidemia | 20 (76%) |
| Hypertension | 19 (73%) |
| Atrial fibrillation | 8 (31%) |
| Diabetes | 6 (23%) |
| Obstructive Sleep Apnea | 5 (19%) |
| Tobacco use (in past 5 years) | 4 (15%) |
| Coronary artery disease | 2 (8%) |
| Prior stroke (%) | 25 (96%) |
| Two or more strokes (%) | 7 (27%) |
| Prior TIA (%) | 5 (19%) |
| Median months since stroke/TIA (IQR) | 4 (2) |
| Median months study duration (IQR) | 18 (6) |
| Median study visits (IQR) | 4 (2) |
| Median baseline NIH stroke scale (IQR) | 0 (1) |
| Median baseline modified rankin score | 1 (1) |
| Median chronic infarct volume ml (IQR) | 0.7 (1.8) |
| Median baseline WMH volume ml/% of TICV (IQR) | 16 (19)/1.0% (1.2) |
| Median voxel-wise WMH growth ml/% of TICV (IQR) | 2.9 (2.6)/0.22% (0.19) |
SD, standard deviation; IQR, interquartile range; CV, cerebrovascular; TIA, transient ischemic attack; WMH, white matter hyperintensity; TICV, total intracranial volume.